Ebenbuild

📍 München, Germany🗓 Founded 2019👥 30 employees💰 Last funded Mar 2022
Software Development🌐 ebenbuild.com
Website LinkedIn
Ebenbuild is a digital health tech pioneer developing precise, patient-specific simulation models of lungs based on patient data, so-called digital twins of the lungs. Its digital toolset is based on physics-based simulation, AI, and data science and is designed to support decision makers in the life sciences industry, clinicians, and physicians. Ebenbuilds approach provides a better understanding of respiratory diseases and individual pathophysiology enabling a new class of products and services ranging from in silico trials to accelerate and de-risk the development of inhaled drugs to personalized treatment options that improve the chances of survival and recovery in millions of cases of respiratory conditions such as Acute Respiratory Distress Syndrome (ARDS) each year.
2
Total investors
0
Early stage
2
Mid stage
0
Late stage
2019
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Germany
2
Frequently asked questions
Who invested in Ebenbuild?
Ebenbuild has 2 investors on record on gritt.io, 2 mid-stage.
When did Ebenbuild last raise funding?
The most recent investment in Ebenbuild recorded on gritt.io was in March 2022.
When was Ebenbuild founded?
Ebenbuild was founded in 2019.
What industry is Ebenbuild in?
Ebenbuild operates in Software Development. Find similar Software Development investors on gritt.io.
Where is Ebenbuild based?
Ebenbuild is headquartered in München, Germany.